RSAR: Post-marketing RX Drug Abuse Surveillance Data - IBH (Data Source)
Past New Requirement Updated
- Agency
-
Food and Drug Administration
Department of Health and Human Services
- Solicitation expected
- Estimated value
- $250,000 to $700,000
- Set-aside
- No set-aside
Forecast facts
- Anticipated award
- NAICS code
- 541990 All Other Professional, Scientific, and Technical Services
- Points of contact
-
- Christopher Scott christopher.scott@fda.hhs.gov
- tbd@fda.gov
Forecast details come from HHS's procurement forecast. Agencies' dates and values are estimates.
About this forecast
The Department of Health and Human Services Food and Drug Administration is seeking a contractor for Post-marketing Prescription Drug Abuse Surveillance Data, classified under the Professional, Scientific, and Technical Services NAICS code (541990). The forecast indicates a new requirement with an estimated solicitation release date of January 1, 2026, and a projected contract award date of March 1, 2026. This recompete opportunity for Fiscal Year 2026 appears to focus on collecting and analyzing surveillance data related to prescription drug abuse.
The primary point of contact for this opportunity is Christopher Scott, who can be reached at christopher.scott@fda.hhs.gov within the Food and Drug Administration. While specific award values and detailed contract specifications are not currently available, the opportunity is listed as a non-set-aside contract, suggesting open competition for potential vendors. The contract appears to be a data-driven research project, likely requiring sophisticated analytical capabilities in pharmaceutical and public health surveillance.
Forecast text
Post-marketing RX Drug Abuse Surveillance Data - IBH (Recompete FY26)
On GovTribe
Work this forecast
- Track it in your pipeline
- Find teaming partners
- Similar forecasts
- Ask GovTribe AI about this forecast